Back to search

Amgen Ltd

73 contracts won£4,870,352,985 total value

Every public sector contract Amgen Ltd has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Amgen Ltd for you, and alerts you the moment a renewal goes live.

Where they win

The sectors, tender types and buyers where Amgen Ltd wins most often.

See every live NHS tenders and find your next contract before they do.

See all NHS buyers and UK contract awards.

Sectors

Healthcare & Medical73

Top Buyers

NHS England
12 contracts
£4,703,489,811
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
5 contracts
£95,770,218
Osakidetza
3 contracts
£4,916,280
AOK Baden-Württemberg
2 contracts
£429,000
Servicio Gallego de Salud
2 contracts
£7,189,605
The NHS Commissioning Board (operating under the name of NHS England)
2 contracts
Centre Hospitalier Régional de Verviers
1 contract
£24,658
Chirec
1 contract
£991,800

Awards(73)

Sort:

Belgium – Pharmaceutical products – Fourniture de Denosumab SC sous forme d'un accord-cadre

Centre Hospitalier Régional de Verviers
Belgium
€24,658
Awarded 30 Sept 2026

Ustekinumab

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Cardiff
£6,532,463
Awarded 7 Aug 2026
Ends 30 Jun 2028
Awarded

Belgium – Pharmaceutical products – Denosumab SC

Belgium
€233,448
Awarded 9 Jul 2026
Ends 8 Jul 2030

Spain – Pharmaceutical products – CBAM 578/2025 AMGEN/01

SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA
Spain
€673,077
Awarded 13 Jun 2026
Ends 18 May 2028
Awarded

Spain – Pharmaceutical products – JAEN CBAM AMGEN, S.A. AM 1229/2024

Spain
€335,328
Awarded 6 Jun 2026
Awarded

Spain – Pharmaceutical products – Acuerdo Marco Suministro (CONTR 2025 0000563560)

Central Provincial de Compras de Almería.
Spain
€1,226,213
Awarded 11 May 2026
Awarded

Belgium – Various medicinal products – Denosumab

Belgium
€7,551
Awarded 1 Apr 2026
Ends 31 Mar 2030

Know when Amgen Ltd's contracts come up for renewal

Business predicts when each of these contracts is due to be re-tendered, follows Amgen Ltd for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.

Page 1 of 4

Why track Amgen Ltd?

Amgen Ltd is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.

How renewal tracking works

We aggregate Amgen Ltd's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.

What you can do here

  • Review the full history. Every contract Amgen Ltd has won, with the buyer, value and dates for each.
  • Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
  • Track and get alerted. Follow Amgen Ltd and be notified when their contracts come up again (Business).
  • Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.

Frequently asked questions

Where does this data come from?

Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.

Is the contract history free?

Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.

How do you predict renewals?

From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.